⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

September 4, 2024

Table S1 from IL-15/IL-15Rα-Fc-Fusion Protein XmAb24306 Potentiates Activity of CD3 Bispecific Antibodies through Enhancing T-Cell Expansion

Ji Li Robyn Clark Dionysos Slaga Kendra N. Avery Ke Liu Suzanne Schubbert Rajat Varma Eugene Y. Chiang Klára Tótpál Matthew J. Bernett Patrick G. Holder Teemu T. Junttila

View Full Paper

Ask AI

Bookmark

Share

Abstract

Supplementary table S1 shows the effects of XmAb24306 on EC50 of TDB in vitro killing

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Li et al. (2024) studied this question.

synapsesocial.com/papers/68e59691b6db643587531384 https://doi.org/10.1158/1535-7163.26934999

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Table S1 from IL-15/IL-15Rα-Fc-Fusion Protein XmAb24306 Potentiates Activity of CD3 Bispecific Antibodies through Enhancing T-Cell Expansion2024
2Figure S3 from IL-15/IL-15Rα-Fc-Fusion Protein XmAb24306 Potentiates Activity of CD3 Bispecific Antibodies through Enhancing T-Cell Expansion2024
3Figure S1 from IL-15/IL-15Rα-Fc-Fusion Protein XmAb24306 Potentiates Activity of CD3 Bispecific Antibodies through Enhancing T-Cell Expansion2024
4Figure S2 from IL-15/IL-15Rα-Fc-Fusion Protein XmAb24306 Potentiates Activity of CD3 Bispecific Antibodies through Enhancing T-Cell Expansion2024
5Data from IL-15/IL-15Rα-Fc-Fusion Protein XmAb24306 Potentiates Activity of CD3 Bispecific Antibodies through Enhancing T-Cell Expansion2024